Market Chatter: Novo Nordisk to Manufacture Wegovy in Ireland Facility
MT Newswires Live
Feb 13
Novo Nordisk (NVO) is planning to boost its investment in Ireland where it will make its Wegovy weight-loss pill for markets outside the US, Bloomberg reported Thursday, citing an interview with Mike Doustdar, the company's CEO.
The company will expand its facility in Athlone to manufacture the weight-loss drug, Doustdar said.
Novo Nordisk didn't immediately respond to MT Newswires' request for comment.
(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.